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ABSTRACT: The theory for measuring ligand binding constants from footprinting autoradiographic data 
associated with a single binding site is derived. If the ligand and DNA cleavage agent compete for a common 
site, the spot intensities are not proportional to the amount of DNA not blocked by ligand. The analysis 
of a single site is experimentally illustrated by using results for the anticancer drug actinomycin D interacting 
with the duplex d(TAGCGCTA)2 as probed with the hydrolytic enzyme DNase I. 
F o o t  printing analysis utilizes DNA sequencing methodology 
to locate the binding sites of drugs and proteins on DNA 
molecules of heterogeneous sequence (Galas & Schmitz, 1978; 
Lane et al., 1983; Scamrov & Beabealashvili, 1983; Van Dyke 
et ai., 1982). In the footprinting experiment, DNA which has 
come to equilibrium with a ligand is allowed to interact with 
a probe capable of cutting the DNA at various sites. From 
the amounts of the different oligonucleotide fragments pro- 
duced, one can infer where the ligand binds on the DNA, 
assuming that ligand bound at a DNA site prevents the probe 
from cleaving at that site. In quantitative footprinting studies, 
'Supported by American Cancer Society Grant NP-681. 
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the amounts of fragments produced in the digest are analyzed 
to extract individual site binding isotherms and determine 
ligand binding constants as a function of sequence. It has now 
been demonstrated that one can obtain binding constants for 
ligands on large DNA polymers as well as small oligomers 
(Brenowitz et al., 1986; Carey, 1988; Dabrowiak & Goodis- 
man, 1989; Goodisman & Dabrowiak, 1990; Ikeda & Rich- 
ardson, 1986; Gunderson et al., 1987; Letovsky & Dynan, 
1989; Fish et al., 1988; Brenowitz & Senear, 1989). 
For an oligomer with only one binding site, the quantitative 
analysis of footprinting data is quite simple, but not without 
pitfalls. In the present paper, we show the correct method for 
extracting the ligand-DNA binding constant from footprinting 
0 1990 American Chemical Society 
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data for a single-site situation and point out how an apparently 
sound treatment leads to anomalous results. It is sometimes 
assumed that the measured autoradiographic spot intensities 
within a ligand binding site are proportional to the fraction 
of that site unoccupied by ligand but, as was recently pointed 
out (Dabrowiak & Goodisman, 1989; Ward et al., 1988), this 
is true only if the amount of DNA to which the cleavage agent 
can bind is not significantly changed as ligand is added to the 
system. For example, with the enzyme DNase I or the syn- 
thetic compound Fe-MPE, which cleave DNA with little or 
no sequence specificity, the proportionality holds well (Ward 
et al., 1988; Dabrowiak et al., 1989a). Since the ratio of 
ligand-blocked DNA to unblocked DNA is small for large 
restriction fragments, the effective concentration of the 
cleavage agent or probe at a site does not significantly increase 
as ligand is added. However, if the specificity of the cleavage 
agent is high and is similar to the specificity of the ligand being 
studied, the proportionality between spot intensity and fraction 
of site unoccupied may not hold. This occurs for a case re- 
cently examined by us, in which the probe was the cationic 
metalloporphyrin complex MnT4MPyP and the ligand the 
antiviral agent netropsin, both of which compete for AT-rich 
sites on DNA (Dabrowiak et al., 1989b). 
In this report, we consider a small oligonucleotide duplex 
possessing a single actinomycin binding site. In this case, in 
which ligand and probe compete for a very limited amount 
of DNA, the lack of proportionality between the autoradio- 
graphic spot intensity, on one hand, and 1 minus the occupancy 
of the site by a drug molecule, on the other, has important 
consequences We show that incorrectly assuming this pro- 
portionality can have a significant effect on the binding con- 
stants derived from footprinting data. This explains why the 
binding constants recently reported from analysis of foot- 
printing data for netropsin and distamycin bound to small 
oligonucleotide duplexes are anomalously low (Fish et al., 
1988). We apply a correct analysis to footprinting data for 
binding of actinomycin D on a small oligomer and derive the 
binding constant for this drug. 
EXPERIMENTAL PROCEDURES 
The self-complementary oligonucleotide d(TAGCGCTA)2 
was synthesized on a Biosearch 8600 synthesizer and purified 
by using a Waters Associates HPLC. The molar extinction 
coefficient of the oligonucleotide was determined by measuring 
the difference in optical absorbance of a sample at 259 nm 
before and after exhaustive digestion with snake venom 
phosphodiesterase (Sigma) in a buffer of 100 mM ammonium 
acetate (pH 7.5). The molar extinction coefficient of the 
mixture of mononucleotides was determined by using the ex- 
pected molar ratios of the mononucleotides present and their 
individual molar extinction coefficients. The value of tM found 
for d(TAGCGCTA)2 was 1.58 X lo5 M-’ cm-’. Actinomycin 
D concentrations were measured optically with a value of tM 
of 24400 M-I cm-’ at 440 nm. 
The oligonucleotide was labeled at its 5’ end using [y -  
32P]ATP/polynucleotide kinase and purified via electrophoresis 
in a 25% polyacrylamide gel containing 6 M urea (Maniatis 
et al., 1982). The DNase I footprinting reactions were carried 
out in a total volume of 8 pL, for 10 min at 25 OC, in a buffer 
consisting of 10 mM Tris (pH 7.5), 8 mM MgC12, and 2 mM 
CaCl,. Thirteen different final drug concentrations between 
1 and 12 pM, associated with two separate footprinting ti- 
trations, were preincubated with the DNA prior to the addition 
of the enzyme. The final concentration of DNA present in 
all experiments was 24.3 pM in base pairs (3.04 pM in duplex) 
while the enzyme concentration was about 0.2 pM. After the 
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reaction was quenched by the addition of urea, the oligo- 
nucleotide products were loaded into a 25% polyacrylamide 
gel and separated via electrophoresis. The resulting autora- 
diograms were scanned to yield band areas proportional to 
concentrations. The intensities derived from three of the 
cleavage products were used in the analysis in the drug con- 
centration range 1-4 pM. 
SINGLE-SITE MODEL 
Since DNase I must bind to DNA in order to cleave it, the 
rate at which cleavage occurs at a particular site i is pro- 
portional to up, the probability that an enzyme molecule is 
bound at that site, or the fraction of sites i having an enzyme 
molecule bound. If the enzyme digest is allowed to proceed 
only until about 30% of the DNA is cleaved (the “single-hit” 
regime), the number of oligonucleotide fragments due to 
cleavage at i is proportional to the initial cleavage rate. The 
spot intensity or band area on the autoradiogram corresponding 
to cleavage at site i, I,, is proportional to the concentration of 
the corresponding fragment produced, i.e. 
Ii = kiup (1) 
with ki a constant. If the ratio of the ligand-blocked DNA 
to unblocked DNA is small, the quantity up is proportional to 
pi ,  the probability that site i is not blocked to the enzyme, and 
to the concentration of enzyme at the site, which will be de- 
termined by the fraction of sites available to the enzyme. 
Then, in eq 1, one can put k,qDNase I]p, for k,up (ki’ a 
constant), as in previous work (Ward et al., 1988). In the 
present, single-site, case, we calculate up by considering a 
competitive binding equilibrium between the ligand and the 
probe. 
Because the binding constant for the ligand will be higher 
than that for the probe, a ligand molecule binding at a site 
will generally displace a probe molecule. If enough probe is 
available to saturate the site in the absence of ligand (vp N 
l ) ,  up in the presence of ligand will indeed be equal to p i  or 
1 - ui, where vi is the fraction of binding site occupied by ligand. 
However, in general, up will be only approximately proportional 
to 1 - uir and, as we show below, small deviations from the 
proportionality of the amount of cleavage product to 1 - vi can 
be very important and lead to major errors in equilibrium 
binding constants derived from footprinting data. 
We consider a DNA oligomer, with one site which may be 
occupied either by the ligand or by the probe, i.e., simultaneous 
occupancy is not possible. Let c be the concentration of oli- 
gomer, P, the total concentration of probe, and D, the total 
concentration of ligand. It should be noted that one generally 
knows D,, whereas it is the concentration of free ligand which 
enters the binding constant expressions. Since there is only 
one site per oligomer, we suppress the site index i ,  so that I 
represents the autoradiographic spot intensity (proportional 
to the concentration of cleavage product produced in the di- 
gest) and t$, represents the fraction of site occupied by ligand. 
The “footprinting plot” is I as a function of D, (Ward et al., 
1988; Dabrowiak & Goodisman, 1989). 
According to eq 1, I will be proportional to up, where vb and 
vp are determined by the equilibrium expressions: 
(2) 
(3) 
cub K =  
( c  - cub - Cvp)(Dt - cub) 
CUP K p  = 
( c  - cvb - cvp)(P, - cup) 
Here, K is the binding constant for ligand to the site and Kp 
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FIGURE 1 : Bjer” plots for a single site using the correct and apparent 
free ligand concentrations are shown. The inset shows the relationship 
between the true fraction of site occupied by the ligand, Vb, and the 
apparent occupancy as measured from autoradiographic intensities. 
the binding constant of the probe to the same site. The object 
of the analysis of footprinting data is the determination of K: 
we expect that, for this and similar systems, K >> Kp’ In the 
absence of ligand (0, = t+, = 0), up becomes vpo; eq 3 gives 
P, + c + K;’ - d(Pt  + c + KL1)2 - ~ c P ,  
7” up0 = 
L L  
Let Io be the value of I in the absence of ligand; Io is pro- 
portional to upo. 
In the presence of ligand, eqs 2 and 3 must be solved si- 
multaneously. One obtains a cubic equation for up, which may 
be written 
[U;C - up(Pt + c + K;’) + P,][up~(K - Kp) + K$,] + 
Given values for K and Kp, eq 4 may be solved numerically 
for any desired values of c, P,, and 0,. Then I l l o  = up/upo.  
The data one generally has to analyze consist of experimental 
values of I ,  which are proportional to the amount of oligo- 
nucleotide produced in the digest, as a function of D,, with c 
and P, constant. Our procedure (Dabrowiak et al., 1989b) 
is to seek the values of K and Kp which give calculated I as 
a function of D, in closest possible agreement with experiment. 
The quantity 1 - I / Io  is sometimes referred to as the “degree 
of protection”. If one assumes that the degree of protection 
is equal to Yb, one can calculate the free ligand concentration 
as D, - c(l - Z / Z o )  and write eq 2 as 
u,K(u,c - PJK, = 0 (4) 
1 - I / I o  
( I / l o ) [ D ,  - 4 1  - I/IO)l 
K =  
From a plot of I / I o  as a function of D,, one can then easily 
determine K. As we will now show, such a procedure can lead 
to large errors because the actual free ligand concentration, 
D, - Cub, can be very different from D, - c(1 - Z/Zo) .  
We first show calculated results, based on eq 4, using the 
experimental parameters c = 8.85 pM, P, = 1 pM, and D, 
between 0 and 200 pM (Fish et al., 1988). We assume K = 
IO7 M-’ and Kp = 5 X lo4 M-I. We calculate up, and I l l o  
= up/upo [upo is small here (0.0338) because the binding con- 
stant Kp is small]. The degree of protection,f= 1 - Z/Zo, starts 
at 0 for D, = 0. As D, increases,frises, at first almost linearly 
with D,, and then levels off as the ratio of D, to c approaches 
unity. 
In the inset of Figure 1, Vb is plotted against 1 - Z/Zo.  The 
deviation of this curve from a line of unit slope shows the error 
in assuming that vb is equal to$ Although the deviation does 
not appear large, it in fact leads to enormous errors in the 
determination of the ligand binding constant. For an equi- 
FIGURE 2: Desitometric scan of autoradiographic data of DNase I 
cleavage of d(TAGCGCTA)2 is shown. The cleavage products 
represented by peaks 2-4 were used in the analysis. Peak 1 is the 
uncleaved oligomer. 
librium like eq 2, one often determines K experimentally by 
plotting measured values of vb against x,  the negative logarithm 
of the free ligand concentration (Bjerrum plot). The value 
of x for which ub = should be log K. In Figure 1 , f i s  
plotted against x .  For the right-hand plot (points represented 
by squares), which resembles a Bjerrum plot, the correct free 
ligand concentration is used, i.e., D, - vbc; for the left-hand 
plot (circles), the apparent free ligand concentration, D, - fc, 
is used. 
The two plots are obviously quite different. The left-hand 
plot does not have a shape like a Bjerrum plot, and the ap- 
parent value of K (from the value of x which makes ub = 1/2) 
is close to lo6, which is an order of magnitude lower than the 
true value. Even for the values of Kp and K used here, the 
assumption f = Vb leads to very large errors in the free ligand 
concentration. The correct value of K is obtained from the 
right-hand plot, 1 - I/Zo vs -log (0, - Vbc). The value obtained 
for log K is actually slightly below 7 because of the slight 
difference between 1 - I/Zo and Vb, a difference which has a 
large effect on the calculated free ligand concentration. 
One should expect that, if one plotsf = 1 - I/Zo against the 
negative logarithm of 0, - fc, the data may not fit a Bjerrum 
plot, even if Kp is several orders of magnitude less than K. 
Indeed, from such a plot, one can judge whether the as- 
sumptionf = ub is justified. If the shape of the plot is very 
different from a Bjerrum plot [for example, the slope at vb = 
should be (4 log e ) - ’ ] ,  a more accurate analysis, such as 
the following, is required to obtain K. 
ACTINOMYCIN D BINDING TO D(TAGCGCTA), 
DNase I cleavage of d(TAGCGCTA)* produces three major 
oligonucleotide products, shown in Figure 2. When actino- 
mycin D (Act-D) is added to the system, the amount of each 
of the products decreases in the manner shown in Figure 3. 
The fact that no enhancements are observed as drug is added 
(Figure 3) shows that drug displaces enzyme from the duplex 
and thus drug and enzyme compete for a common DNA site. 
For this duplex, with two GC dimers, there are two equivalent 
binding sites for actinomycin D. However, there is room to 
bind only one drug molecule to the duplex, so that one bound 
drug should exclude binding of a second drug or the enzyme. 
Scott et al. (1988) reported that two actinomycin D molecules 
can bind to the sequence 5’-GCGC-3’ but that the second drug 
binds in an anticooperative manner with a binding constant 
for the second drug a factor of 20 lower than that of the first 
Act-D molecule. Since only the early part of the footprinting 
titration was used in this analysis, a duplex possessing two 
bound Act-D molecules was not part of our model. 
We treat the situation as if there were two mutually ex- 
clusive binding sites, rather than a single site, and ligand 
binding at either site blocked cleavage by DNase I. To take 
into account the presence of two mutually exclusive binding 
780 Biochemistry, Vol. 29, No. 3, 1990 
A 
0.06 
Rehfuss et al. 
5 
O l 0 l  : 
FIGURE 3: Intensities of peaks 2-4 of Figure 2 as a function of 
actinomycin D concentration. Footprinting plots, for two separate 
experiments (A and B), are shown. Closed symbols are experimental 
intensities while the open symbols are the calculated values using the 
model described in the text. 
sites, we have to modify eqs 2 and 3 slightly. 
Let K, and K2 be the equilibrium constants for binding of 
drug at the two sites and ul and u2 the fraction of oligomers 
which have drug bound at the two sites. Then, analogously 
to eq 2 
( 5 )  
and similarly for site 2. In eq 3, one has to substitute u1 + 
u2 for ub Adding together eq 5 and the corresponding equation 
for site 2, we have 
cv I 
( C  - C U I  - C U Z  - C Y ~ ) ( D ~  - C U I  -  CY^) K1 = 
Thus, we recover eq 2, except that now K represents K, + K, 
and u represents ul  + u2.  The data can be analyzed as a 
single-site problem, except that, if the two sites are equivalent 
(K, = K 2 ) ,  the resulting equilibrium constant actually repre- 
sents twice the actual site binding constant. 
Two sets of footprinting data, each consisting of autora- 
diographic spot intensities for three cleaved fragments, were 
analyzed to obtain the equilibrium binding constant of Act-D. 
One drug binding site with binding constant K was assumed, 
such that drug binding blocks the cutting events leading to the 
three fragments. Thus, the equilibrium binding constant for 
a single drug binding mode is K/2. The analysis involves 
calculating Vb as a function of drug concentration, assuming 
particular values of the binding constants K and Kp, and 
seeking the values of K and Kp which give the minimum de- 
viation between experimental and calculated data. For each 
of the two footprinting titrations, the data for all three sites, 
at all the concentrations shown, were used simultaneously, and 
fit with the same values of K and K p .  
In Figure 3, we show experimental and theoretical foot- 
printing plots, the latter calculated with the values of K and 
Kp which minimize D, the deviation between experimental and 
calculated data. The agreement between experiment and 
'1 g l  
a 
.:j .' : 
5-1 1; 13 10*3 10' 
1 
106 107 io8 
-" 
K* K 
FIGURE 4: Relationship between 0, the deviation between experimental 
and calculated data, and the binding constant of DNase I to DNA, 
K p  (left panel), and the binding constant of actinomycin D, K (right 
panel), to DNA. 
theory is within the experimental error, as judged from the 
scatter in the experimental points. From the first set of data 
(Figure 3A), we find K = 7 X lo6 M-' and Kp = 10 M-l; the 
second set (Figure 3B) yields K = 9 X lo6 M-' and Kp = 20 
M-I. In Figure 4, we show, for the data of Figure 3A, D as 
a function of K p  with K fixed at  7 X lo6 M-l, and D as a 
function of K with K p  fixed at 10 M-I. These plots allow an 
estimate of the precision of the determined equilibrium con- 
stants. The value of Kp, the binding constant of DNase I 
toward DNA, is not accurately determined. However, it is 
less than about lo4 M-I. The determined value of K is good 
to about f 3  X lo6, since changing K by more than this leads 
to an increase in D by 10%. 
The Act-D binding constant toward a single site on the 
8-mer derived in this study (-4 X lo6 M-I) is in good 
agreement with the results of other binding studies using 
classical techniques. For example, although the salt conditions 
were not the same as those used in this study, the sequence 
AGCT in d(ATAAGCTTAT)2 binds Act-D with a binding 
constant of 5 X lo6 M-l (Chen, 1988). The binding constant 
is somewhat sequence dependent. If the GC site is flanked 
by C and G, as is the case for d(ATACGCGTAT),, the 
binding constant exhibits a slight increase to 8 X 106 M-'. This 
work confirms the utility of quantitative footprinting analysis 
for obtaining binding constants of drugs to DNA. 
CONCLUSIONS 
In this paper, we analyze the footprinting experiment as- 
sociated with a single site involving a competitive equilibrium 
between the cleavage agent and a DNA binding ligand. In 
this case, the lack of proportionality between the autoradio- 
graphic spot intensities and 1 minus the occupancy of the site 
by the ligand has particularly marked consequences. Assuming 
that the proportionality is valid can lead to measured binding 
constants which are too low, as seems to have occurred for the 
recently reported binding constants of netropsin and dista- 
mycin, which are significantly lower than those expected for 
these drugs interacting with the duplex d(GGTATACC)2 (Fish 
et al., 1988). The analysis presented also applies to protein- 
DNA footprinting experiments involving DNase I as well as 
other chemical cleaving agents, e.g., Fe-MPE. If the ratio of 
protein-blocked sites to free sites on DNA is small, the au- 
toradiographic spot intensities associated with binding will be 
nearly proportional to the amount of free DNA not blocked 
by protein. This situation will arise if the fragment on which 
binding is occurring is long or if it is short but additional 
nonlabeled DNA is present in the system which can bind the 
cleavage agent but not the protein. If the fragment is small, 
the spot intensities will not be proportional to 1 minus the 
Biochemistry 1990, 29, 78 1-788 78 1 
fraction of site bound by ligand, and care must be taken in 
the analysis of the data. 
Registry No. DNase 1,9003-98-9;d(TAGCGCTA), 115710-85-5; 
actinomycin D, 50-76-0. 
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Thermal Stability of Membrane-Reconstituted Yeast Cytochrome c Oxidase7 
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ABSTRACT: The thermal dependence of the structural stability of membrane-reconstituted yeast cytochrome 
c oxidase has been studied by using different techniques including high-sensitivity differential scanning 
calorimetry, differential detergent solubility thermal gel analysis, and enzyme activity measurements. For 
these studies, the enzyme has been reconstituted into dimyristoylphosphatidylcholine (DMPC) and di- 
elaidoylphosphatidylcholine (DEPC) vesicles using detergent dialysis. The phospholipid moiety affects the 
stability of the enzyme as judged by the dependence of the denaturation temperature on the lipid composition 
of the bilayer. The enzyme is more stable when reconstituted with the 18-carbon, unsaturated phospholipid 
(DEPC) than with the 14-carbon saturated phospholipid (DMPC). In addition, the shapes of the calorimetric 
transition profiles are different in the two lipid systems, indicating that not all of the subunits are affected 
equally by the lipid moiety. The overall enthalpy change for the enzyme denaturation is essentially the 
same for the two lipid reconstitutions (405 kcal/mol of protein for the DMPC and 425 kcal/mol for the 
DEPC-reconstituted enzyme). In both systems, the van? Hoff to calorimetric enthalpy ratios are less than 
0.2, indicating that the unfolding of the enzyme cannot be represented as a two-state process. Differential 
detergent solubility experiments have allowed us to determine individual subunit thermal denaturation profiles. 
These experiments indicate that the major contributors to the main transition peak observed calorimetrically 
are subunits I and I1 and that the transition temperature of subunit I11 is the most affected by the phospholipid 
moiety. Experiments performed at  different scanning rates indicate that the thermal denaturation of the 
enzyme is a kinetically controlled process characterized by activation energies on the order of 40 kcal/mol. 
These studies have allowed us to quantitatively model the thermal denaturation mechanism of the enzyme. 
x e  formation of functionally active integral membrane 
protein assemblies involves membrane insertion, folding, and 
subunit association of the constituent polypeptide units. The 
molecular details and energetics of those processes are still not 
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3791 1 and RR 04328). 
completely understood. Cytochrome c oxidase is the terminal 
enzyme of the respiratory chain, catalyzing the transfer of 
electrons from cytochrome c to molecular oxygen while si- 
multaneously serving as a proton pump. Cytochrome c oxidase 
is a multisubunit enzyme composed of mitochondrially syn- 
thesized subunits and subunits imported from the cytoplasm. 
In most species, the three largest subunits (I, 11, 111) are 
synthesized in the mitochondria and the remaining subunits 
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